Femasys (FEMY) Non Operating Income (2020 - 2025)
Femasys' (FEMY) quarterly Non Operating Income came in at -$734356.0 in Q2 2025, down 259.67% YoY from $459911.3 in Q2 2024, and down 66.74% on a QoQ basis from -$440420.0 in Q1 2025.
Femasys (FEMY) Non Operating Income (2020 - 2025) Analysis & Trends
Femasys (FEMY) has 6 years of Non Operating Income data on file, last reported at -$734356.0 in Q2 2025.
- Quarterly Non Operating Income fell 259.67% year-over-year to -$734356.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$1.9 million (down 769.72% YoY) and the FY2025 annual result came in at -$1.0 million, down 1.64% from the prior year.
- Non Operating Income declined to -$734356.0 in Q2 2025, from -$440420.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $818016.0 in Q2 2021 to a low of -$802308.0 in Q4 2021.
- A 5-year average of -$94863.4 and a median of $906.5 in 2021 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 45095.38% in 2021, down 389569.9% in 2021.
- Tracing FEMY's Non Operating Income over 5 years: stood at -$802308.0 in 2021, then surged by 112.82% to $102822.0 in 2022, then slumped by 57.79% to $43399.0 in 2023, then slumped by 1000.75% to -$390918.0 in 2024, then sank by 87.85% to -$734356.0 in 2025.
- The last three Non Operating Income figures came in at -$734356.0 (Q2 2025), -$440420.0 (Q1 2025), and -$390918.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | - |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 597,644.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -734,356.00 |
| Mar 31, 2025 | -440,420.00 |
| Dec 31, 2024 | -390,918.00 |
| Sep 30, 2024 | -289,262.00 |
| Jun 30, 2024 | -204,173.00 |
| Mar 31, 2024 | -136,868.00 |
| Dec 31, 2023 | 43,399.00 |
| Sep 30, 2023 | 84,359.00 |
| Jun 30, 2023 | 42,454.00 |
| Mar 31, 2023 | 97,089.00 |
| Dec 31, 2022 | 102,822.00 |
| Sep 30, 2022 | 74,346.00 |
| Jun 30, 2022 | 26,745.00 |
| Mar 31, 2022 | -280.00 |
| Dec 31, 2021 | -802,308.00 |
| Sep 30, 2021 | 1,649.00 |
| Jun 30, 2021 | 818,016.00 |
| Mar 31, 2021 | 164.00 |
| Dec 31, 2020 | 206.00 |
| Sep 30, 2020 | -3,418.00 |